BridgeMD
New treatment option for Aphasia
Official title Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
ClinicalTrials.gov ID: NCT04142866
What this study is testing
- What it's testing
- The purpose of this study is to assess changes in language abilities of participants with chronic, post-stroke aphasia following an 8-week therapy period combined with brain stimulation. The investigators use a stimulation method called transcranial direct current stimulation (tDCS).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 80. Healthy volunteers may be eligible.
You may be able to join if
- This study recruits individuals with post-stroke aphasia as well as a group of healthy volunteers matched for age, sex, and education.
- Right handed (pre-stroke for participants with aphasia)
- High school education or equivalent
- Native English fluency without early 2nd language exposure (before age 10)
- Ability to perform the required discourse and MRI tasks (determined via in-person screening) Additional for participants with APHASIA:
You likely can't join if
- Failed vision or hearing screening
- MRI contraindications (including pacemaker)
- Pregnancy
- History of seizure or change in seizure medication in past 12 months
- History of speech/language, psychiatric, or neurological disorder, or current serious medical condition (except chronic stroke comorbidities for...
- Unmodifiable hair style precluding scalp contact by electrodes
See the full eligibility criteria
- This study recruits individuals with post-stroke aphasia as well as a group of healthy volunteers matched for age, sex, and education.
- Right handed (pre-stroke for participants with aphasia)
- High school education or equivalent
- Native English fluency without early 2nd language exposure (before age 10)
- Ability to perform the required discourse and MRI tasks (determined via in-person screening) Additional for participants with APHASIA:
- Single-event left hemisphere stroke \> 6 months prior to enrollment
- Aphasia diagnosis per Western Aphasia Battery-Revised
- Not receiving any other speech therapy for the entire study period (20 weeks)
- Ability to perform the required therapy tasks (determined via in-person screening)
- Failed vision or hearing screening
- MRI contraindications (including pacemaker)
- Pregnancy
- History of seizure or change in seizure medication in past 12 months
- History of speech/language, psychiatric, or neurological disorder, or current serious medical condition (except chronic stroke comorbidities for participants with aphasia) Additional EXCLUSION criteria for participants...
- Unmodifiable hair style precluding scalp contact by electrodes
- Sensitive scalp by self-report
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 80 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.